PGE2 can also act on human type 1 conventional dendritic cells (DCs) leading to anti-tumor dysfunction by downregulating their expression of T cell recruiting chemokine ligands such as CXCL9 and CXCL10 and production of IL-12 which could also impair NK cell function (97). Here, CXCL10 is linked to neoplasm.